Italian Validation of the Pelvic Floor Distress Inventory (PFDI-20) Questionnaire
NCT ID: NCT05472129
Last Updated: 2022-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2021-10-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pelvic Floor Signs and Symptoms in Women and Men
NCT03558802
A National Observation Study on Pelvic Floor Dysfunction Diseases in China
NCT06037226
Assessment of Quality of Life in Disorders of the Pelvic Floor
NCT01134588
Pelvic Floor Muscle Activity in Primary Dysmenorrhea
NCT06803173
Educational Intervention Related to Pelvic Floor Care in Females in Sport: ACTITUD
NCT06355297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The endpoint is the evaluation of the validity, internal consistency, and test-retest reliability.
Study participants will be patients referred to the urogynecological outpatient for pelvic floor disorders (genital prolapse and/or urinary incontinence). Cases and controls were defined, as done previously, with respect to bowel, bladder or prolapse symptoms using the question: "How much do your symptoms bother you?" and the following choice of answers: "Not applicable - I do not have symptoms", "not at all", "a little", "quite a lot" and "very much". Controls were identified as women answering "Not applicable - I do not have symptoms" or "not at all", otherwise patients were defined as cases.Patients will be asked to complete the self-reported questionnaire to evaluate the presence and the severity of pelvic floor symptoms. For the test-retest evaluation, cases will receive the questionnaire two weeks later by email. Questionnaire distribution and all interviews will be undertaken by the authors. Cases will report the identification code on the questionnaire in order to associate the first questionnaire with the retest one. Patients will return the retest questionnaire as soon as possible (by email or in outpatient).
Total scores for women with and without significant symptoms will be compared and tested for statistical differences in order to assess validity. Given the heterogeneity of variances, Wilcoxon test (non-parametrical) will be used to assess differences between case and controls. Convergent validity will not be tested since there is no Italian questionnaire available for comparison. The internal consistency - the strength of association among items will be tested using Cronbach's Alpha. Cases will be given the questionnaire at baseline and two week later to evaluate the test-retest reliability. The test-retest reliability analysis will be aimed to determine the questionnaire's reproducibility over time. The degree of concordance/agreement will be measured with Cohen's Kappa. In addition, the absolute agreement of test-retest results of different individuals will be tested with the intraclass correlation coefficient (ICC).
Statistical analysis will be performed with JMP 7.0 (SAS, Cary, USA). Where ratings will be missing, items will be excluded from the analysis pool. Patients who will not complete the questionnaire both at baseline and at the test-retest visit will be excluded from the analyses. A p\<0.05 will be considered as significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Cases were defined, with respect to bowel, bladder or prolapse symptoms using the question: "How much do your symptoms bother you?" and the following choice of answers: "Not applicable - I do not have symptoms", "not at all", "a little", "quite a lot" and "very much".
self-administered questionnaires
The validation process of a linguistic translation must maintain conceptual and technical equivalence between the source and the target language.The questionnaire was submitted to women during a gynecological medical interview and they were asked to evaluate their perceived degree of difficulty in understanding each question item. After that, the final Italian version of the questionnaire was obtained
Control
Controls were identified as women answering "Not applicable - I do not have symptoms" or "not at all", otherwise patients were defined as cases.
self-administered questionnaires
The validation process of a linguistic translation must maintain conceptual and technical equivalence between the source and the target language.The questionnaire was submitted to women during a gynecological medical interview and they were asked to evaluate their perceived degree of difficulty in understanding each question item. After that, the final Italian version of the questionnaire was obtained
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
self-administered questionnaires
The validation process of a linguistic translation must maintain conceptual and technical equivalence between the source and the target language.The questionnaire was submitted to women during a gynecological medical interview and they were asked to evaluate their perceived degree of difficulty in understanding each question item. After that, the final Italian version of the questionnaire was obtained
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Informed consent freely granted and acquired before the start of the study
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milano Bicocca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Milano Bicocca
Monza, MB, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ITA PFDI-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.